Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Papillomavirus Infections 9Uterine Cervical Neoplasms 4Neuroendocrine Tumors 4Autoimmune Diseases 3Prostatic Neoplasms 2Neoplasms 2Abortion, Spontaneous 2Recurrence 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neuroblastoma 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

rozanolixizumab 10zilucoplan 7ravulizumab 7efgartigimod alfa 6eculizumab 5fludarabine 4Cyclophosphamide 4telitacicept 3Tacrolimus 3HBM9161 3inebilizumab 2Mycophenolic Acid 2Diagnostic Self Evaluation 2Amifampridine 2satralizumab 1rhoA GTP-Binding Protein 1remibrutinib 1iscalimab 1iptacopan 1Robotic Surgical Procedures 1Prednisone 1Prednisolone 1Plasmapheresis 1Immunoglobulins, Intravenous 1Data Collection 1Cladribine 1CK-2017357 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Myasthenia Gravis × Data Collection × Clear all
NCT04590716 2021-07-29

Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares

doc.ai inc

Completed
113 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡